171 related articles for article (PubMed ID: 21277072)
1. Inhibition of the adhesion to catheters of uropathogenic Escherichia coli by sub-inhibitory concentrations of cefotaxime.
Balagué C; Pérez J; Rinaudo M; Fernández L
Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):150-6. PubMed ID: 21277072
[TBL] [Abstract][Full Text] [Related]
2. Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces.
Bernal-Mercado AT; Gutierrez-Pacheco MM; Encinas-Basurto D; Mata-Haro V; Lopez-Zavala AA; Islas-Osuna MA; Gonzalez-Aguilar GA; Ayala-Zavala JF
J Appl Microbiol; 2020 Feb; 128(2):387-400. PubMed ID: 31573730
[TBL] [Abstract][Full Text] [Related]
3. [Urinary tract infections and their prevention].
González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
[TBL] [Abstract][Full Text] [Related]
4. The effect of nitric oxide on adherence of P-fimbriated uropathogenic Escherichia coli to human renal epithelial cells.
Svensson L; Säve S; Persson K
BJU Int; 2010 Jun; 105(12):1726-31. PubMed ID: 19863519
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
[TBL] [Abstract][Full Text] [Related]
6. Surface properties of Escherichia coli strains responsible for urinary infections.
Romano Carratelli C; Nuzzo I; Galdiero M
Microbiologica; 1987 Jan; 10(1):55-61. PubMed ID: 2883558
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval.
den Heijer CD; Donker GA; Maes J; Stobberingh EE
J Antimicrob Chemother; 2010 Oct; 65(10):2128-33. PubMed ID: 20682565
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance patterns and sequencing of class I integron from uropathogenic Escherichia coli in Lebanon.
El-Najjar NG; Farah MJ; Hashwa FA; Tokajian ST
Lett Appl Microbiol; 2010 Oct; 51(4):456-61. PubMed ID: 20840552
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and Inactivation of Uropathogenic
Narayanan A; Nair MS; Muyyarikkandy MS; Amalaradjou MA
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880781
[TBL] [Abstract][Full Text] [Related]
11. Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli.
Amalaradjou MA; Narayanan A; Baskaran SA; Venkitanarayanan K
J Urol; 2010 Jul; 184(1):358-63. PubMed ID: 20488489
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].
Karam D; Amgar A; Bourlioux P
Pathol Biol (Paris); 1988 May; 36(5):452-5. PubMed ID: 3043342
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
[TBL] [Abstract][Full Text] [Related]
14. Extract of Clinopodium bolivianum protects against E. coli invasion of uroepithelial cells.
Mohanty S; Kamolvit W; Zambrana S; Sandström C; Gonzales E; Östenson CG; Brauner A
J Ethnopharmacol; 2017 Feb; 198():214-220. PubMed ID: 28087472
[TBL] [Abstract][Full Text] [Related]
15. Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli.
Grossman TH; O'Brien W; Kerstein KO; Sutcliffe JA
Antimicrob Agents Chemother; 2015 Apr; 59(4):2446-9. PubMed ID: 25624334
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli.
Roy SM; Riley MA
Int J Antimicrob Agents; 2019 Nov; 54(5):619-625. PubMed ID: 31284040
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity data in support of nitrofurantoin three times per day.
Amábile-Cuevas CF; Arredondo-García JL
J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023
[No Abstract] [Full Text] [Related]
18. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies.
Fraile B; Alcover J; Royuela M; Rodríguez D; Chaves C; Palacios R; Piqué N
Future Microbiol; 2017 Jun; 12():721-731. PubMed ID: 28345957
[TBL] [Abstract][Full Text] [Related]
19. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
[TBL] [Abstract][Full Text] [Related]
20. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation.
Ferrières L; Hancock V; Klemm P
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):212-9. PubMed ID: 17645737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
